Clinical Trials Sponsored by Foundation for Innovative New Diagnostics, Switzerland

Total 81 results

Foundation for Innovative New Diagnostics, Switzerland

Recruiting

BGM and HbA1c POC Device Evaluation

Diabetes

Nigeria, Cambodia, Colombia
Foundation for Innovative New Diagnostics, Switzerland

Completed

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

COVID-19 Respiratory Infection

Switzerland, Uganda, United Kingdom
Foundation for Innovative New Diagnostics, Switzerland

Completed

Clinical Evaluation of tNGS for Diagnosis of DR-TB (Seq&Treat)

Tuberculosis, Multidrug-Resistant

Georgia, India, South Africa
Foundation for Innovative New Diagnostics, Switzerland

Completed

Actionable Results: Bloodstream Infection Molecular Assay Evaluation

Bloodstream Infection

Botswana
Foundation for Innovative New Diagnostics, Switzerland

Completed

Prospective Assessment of TBDx Feasibility

Pulmonary Tuberculosis

Vietnam, Peru
Foundation for Innovative New Diagnostics, Switzerland

Not yet recruiting

Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study (DriveDx4TB)

Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland

Completed

Novel Rapid POC Diagnostics for COVID-19

COVID-19 Respiratory Infection

Georgia, South Africa
Foundation for Innovative New Diagnostics, Switzerland

Completed

Evaluation of the Performance of Rapid Diagnostics for SARS-CoV-2 Self-testing in the Hands of Untrained (CV009)

COVID-19

South Africa, Uganda
Foundation for Innovative New Diagnostics, Switzerland

Completed

Truenat™ HCV RNA Assay Evaluation

Hepatitis C

Denmark, Ethiopia, Georgia, Thailand, Ukraine
Foundation for Innovative New Diagnostics, Switzerland

Completed

Evaluation of the DPP II Assay in Laos

Acute Febrile Illness

Lao People's Democratic Republic
Foundation for Innovative New Diagnostics, Switzerland

Completed

DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

Hepatitis C Virus Infection

Ukraine
Foundation for Innovative New Diagnostics, Switzerland

Completed

Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan (CLeishPOCAFG)

Cutaneous Leishmaniases
Foundation for Innovative New Diagnostics, Switzerland

Completed

Accuracy and Feasibility of Xpert Ultra

Tuberculosis, Pulmonary

Belarus, Georgia, India, South Africa
Foundation for Innovative New Diagnostics, Switzerland

Active, not recruiting

Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2) (Truenat COMBO)

COVID-19 | TB

Uganda
Foundation for Innovative New Diagnostics, Switzerland

Completed

Diagnostic Accuracy of the DPP II Assay

Diagnoses Disease | Acute Febrile Illness | Melioidosis

Australia
Foundation for Innovative New Diagnostics, Switzerland

Completed

Automated Microscopy Evaluation Study (AutoMic)

Malaria

Sudan
Foundation for Innovative New Diagnostics, Switzerland

Completed

Evaluation of Centralised TB Assay Solutions

Tuberculosis | Drug-resistant Tuberculosis

Georgia, Germany, India, Moldova, Republic of, South Africa
Foundation for Innovative New Diagnostics, Switzerland

Completed

Innovation Platform

Malaria

Indonesia, Rwanda
Foundation for Innovative New Diagnostics, Switzerland

Unknown

Performance Evaluation of Malaria Plus RDTs

Malaria
Foundation for Innovative New Diagnostics, Switzerland
UNITAID

Completed

Evaluation of Dried Blood Spot for HCV RNA Testing

Hepatitis C, Chronic

Australia, Cameroon, Georgia, Greece, Rwanda
Foundation for Innovative New Diagnostics, Switzerland
Australian Government

Completed

Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing

Malaria | Diagnoses Disease | RDT

Rwanda
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Recruiting

HCV Self-testing in Pakistan

Hepatitis C | Diagnostic Self Evaluation

Pakistan
Foundation for Innovative New Diagnostics, Switzerland
Universidad de Antioquia

Completed

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women (HSRDT MiP)

Diagnoses Disease | Plasmodium Falciparum | Pregnancy Malaria

Colombia
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of Dengue RDTs

Dengue Fever

Pakistan
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of DPP® Typhoid Assay

Typhoid Fever

Pakistan
Foundation for Innovative New Diagnostics, Switzerland
Kenya Medical Research Institute

Not yet recruiting

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland
Kenya Medical Research Institute

Recruiting

Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya (rK28-AccDemo)

Visceral Leishmaniasis

Kenya
Foundation for Innovative New Diagnostics, Switzerland
Department for International Development, United Kingdom

Completed

Commercial Typhoid Tests Validation Trial

Typhoid Fever

Pakistan, Kenya
Foundation for Innovative New Diagnostics, Switzerland
Institute of Tropical Medicine, Belgium

Completed

Evaluation Study of HCV RDTs in Fresh Samples

Hepatitis C Virus Infection

Georgia, Cambodia
Foundation for Innovative New Diagnostics, Switzerland
Botswana Harvard AIDS Institute Partnership

Completed

COVID-19 Antigen Rapid Test Evaluation in Low-Prevalence Setting (CV006)

Corona Virus Infection

Botswana
Foundation for Innovative New Diagnostics, Switzerland
National Institute of Malaria Research, New Delhi, India

Completed

Clinical Evaluation of the STANDARD™ Q Malaria/CRP Duo Test

Fever Malaria

India
Foundation for Innovative New Diagnostics, Switzerland
University of Khartoum; Eijkman Institute for Molecular Biology

Completed

RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study

Malaria | Diagnoses Disease | RDT

Sudan, Indonesia
Foundation for Innovative New Diagnostics, Switzerland
Burnet Institute; Papua New Guinea Institute of Medical Research

Unknown

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

Diagnoses Disease | Plasmodium Falciparum Malaria | Pregnancy Malaria
Foundation for Innovative New Diagnostics, Switzerland
Ministry of Health, Senegal; Institut Pasteur de Dakar

Recruiting

Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

Pneumonia | Diarrhea | Malaria | Dengue | Acute Febrile Illness | Influenza -Like Illness

Senegal
Foundation for Innovative New Diagnostics, Switzerland
Ministry of Health, Burkina Faso; Terre des hommes, Burkina Faso & Switzerland

Unknown

Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso

Dengue

Burkina Faso
Kenya Medical Research Institute
Foundation for Innovative New Diagnostics (FIND)

Unknown

Commercial Typhoid Tests Validation

Typhoid Fever

Kenya
Foundation for Innovative New Diagnostics, Switzerland
University Hospital, Geneva; B.P. Koirala Institute of Health Sciences

Completed

Cardiometabolic Devices Accuracy Study

Diabetes Mellitus | Chronic Kidney Diseases | Hyperlipidemias

Nepal
Foundation for Innovative New Diagnostics, Switzerland
Ministry of Health, Malaysia; Hospital Sultanah Bahiyah; Malaysian AIDS Council

Recruiting

HCV Self-testing in Malaysia

Hepatitis C | Diagnostic Self Evaluation

Malaysia
Foundation for Innovative New Diagnostics, Switzerland
World Health Organization; World Bank; UNICEF; United Nations Development Programme

Unknown

Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria

Malaria | Malaria in Pregnancy | Placental Malaria

Burkina Faso, Uganda
Foundation for Innovative New Diagnostics, Switzerland
Kenya Medical Research Institute; Frere Hospital, East London, South Africa

Not yet recruiting

Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection (HPV)

Human Papillomavirus Infection
Foundation for Innovative New Diagnostics, Switzerland
The National Center for Disease Control and Public Health; Health Research...

Completed

Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia (HEAD-Start)

Hepatitis C, Chronic

Georgia
Foundation for Innovative New Diagnostics, Switzerland
University of Khartoum; Universidad Peruana Cayetano Heredia; Eijkman Institute...

Completed

Abbott NxTekTM Malaria RDT WHO Prequalification Study

Malaria | Diagnoses Disease | RDT

Indonesia, Peru, Sudan
Macfarlane Burnet Institute for Medical Research...
Foundation for Innovative New Diagnostics, Switzerland; UNITAID; Myanmar Liver...

Completed

Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) (CT2)

Hepatitis C

Myanmar
Foundation for Innovative New Diagnostics, Switzerland
Makerere University; Ministry of Public Health, Democratic Republic of the...

Withdrawn

Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria

Human African Trypanosomiasis
CDx Diagnostics
Foundation for Surgical Innovation and Education

Completed

The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy

Esophageal Diseases | GERD | Barrett Esophagus | Low Grade Esophageal Glandular Dysplasia

United States
Foundation for Innovative New Diagnostics, Switzerland
Institute of Tropical Medicine, Belgium; Research Center Borstel; National Institute...

Completed

Line Probe Assay Evaluation Study (YD)

Multidrug-Resistant Tuberculosis | Isoniazid Resistant Pulmonary Tuberculosis | Rifampicin Resistant Tuberculosis | Pulmonary Tuberculoses
Medecins Sans Frontieres, Spain
International Centre for Diarrhoeal Disease Research, Bangladesh; Foundation... and other collaborators

Unknown

Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection (PRIORITISE)

COVID | SARS-CoV2

Brazil, India
Foundation for Innovative New Diagnostics, Switzerland
Institute of Tropical Medicine, Belgium; Nigerian Institute of Medical Research and other collaborators

Completed

Evaluation Study of RDTs Detecting Antibodies Against HCV

Hepatitis C

Belgium, Georgia, Nigeria
Foundation for Innovative New Diagnostics, Switzerland
Universidad Peruana Cayetano Heredia; Kenya Medical Research Institute; V. N.... and other collaborators

Active, not recruiting

Bioneer IRONqPCR ™ RFIA Kit Kit Clinical Evaluation

Tuberculosis, Multidrug-Resistant

Kenya, Peru, Ukraine
Foundation for Innovative New Diagnostics, Switzerland
The Leona M. and Harry B. Helmsley Charitable Trust; Kenya Diabetes Management...

Not yet recruiting

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya. (ACCEDE)

Type 1 Diabetes

Clinical Trials Sponsored by Foundation for Innovative New Diagnostics, Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations